Young people living in the Bristol area are already helping University of Bristol researchers to understand how children’s immune systems respond to COVID-19, but even more children are needed to take part, especially those from ethnic minorities.
By closely examining the jaw mechanics of juvenile and adult tyrannosaurids, some of the fiercest dinosaurs to inhabit earth, scientists led by the University of Bristol have uncovered differences in how they bit into their prey.
Cleft lip and/or palate are common birth defects and affect around 15 in every 10,000 births in Europe. New research by the University of Bristol from the largest study of cleft lip and/or palate in the world, the Cleft Collective, has found epigenetics could help diagnose different types of cleft.
The origin of animals was one of the most important events in the history of Earth. Beautifully preserved fossil embryos suggest that our oldest ancestors might have existed a little more than half a billion years ago.
Volunteers from the Bristol area are being asked to sign up to the latest COVID-19 vaccine study to be rolled out across the UK.
Around 700 child deaths that occur in England each year might be avoided by reducing deprivation, finds a new NHS England-funded report published today [13 May]. The University of Bristol National Child Mortality Database (NCMD)-led analysis identified a clear association between the risk of death and level of deprivation for children in England, for all categories of death except cancer.
Taking a fresh look at evidence from satellite data, and using the latest theories from complexity science, researchers at the University of Bristol have provided new evidence to show that the Amazon rainforest is not as fragile as previously thought. The research is published today in Nature Communications.
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries.
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
The first ever randomised trial to investigate why some patients develop infections after their hip or knee replacement surgery, and which type of surgical revision treatment is best is being run by the University of Bristol and members of the public are being asked to consider taking part.
